![Steven King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven King
Directeur Général chez
MOSAIC IMMUNOENGINEERING, INC.
Fortune : 291 996 $ au 31/08/2026
Profil
Steven W.
King was the founder of Avid Bioservices, Inc., founded in 2001, where the titles held included President, Chief Executive Officer & Director from 2001 to 2017.
Mr. King is the founder of Mosaic ImmunoEngineering, Inc., founded in 2020, holding the titles of President, CEO, CFO & Director since 2020.
Current jobs include President, Chief Executive Officer & Director at Mosaic ImmunoEngineering Development Co., Director at Oncotelic Therapeutics, Inc. since 2020, and Director at Oncotelic, Inc. Former jobs included President, Chief Executive Officer & Director at Avid Bioservices, Inc. from 2011 to 2017, Chief Executive Officer at Edgepoint, Inc., and Director at Patriot Scientific Corp.
in 2020.
Education includes undergraduate and graduate degrees from Texas Tech University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2025 | 1 641 252 ( 22,66% ) | 188 744 $ | 31/08/2026 | |
| 12/04/2025 | 3 330 647 ( 0,73% ) | 103 250 $ | 31/08/2026 | |
| 21/08/2020 | 161 000 ( 25,56% ) | 2 $ | 31/08/2020 |
Postes actifs de Steven King
| Sociétés | Poste | Début |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/05/2020 |
| MOSAIC IMMUNOENGINEERING, INC. | Directeur Général | 31/08/2020 |
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Directeur/Membre du Conseil | - |
Mosaic ImmunoEngineering Development Co.
 Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Directeur Général | - |
Anciens postes connus de Steven King
| Sociétés | Poste | Fin |
|---|---|---|
| AVID BIOSERVICES, INC. | Directeur Général | 27/11/2017 |
Edgepoint, Inc. | Directeur Général | - |
| PATRIOT SCIENTIFIC CORPORATION | Directeur Général | - |
Avid Bioservices, Inc. /Old/
 Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Provides highly specialized cell cultures for biotechnology testing | Fondateur | - |
Formation de Steven King
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Avid Bioservices, Inc.
 Avid Bioservices, Inc. Pharmaceuticals: MajorHealth Technology Engages in the developing and manufacturing of biologics | Health Technology |
Patriot Scientific Corp.
 Patriot Scientific Corp. SemiconductorsElectronic Technology Develops microprocessors | Electronic Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Texas Tech University
 Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avid Bioservices, Inc. /Old/
Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Provides highly specialized cell cultures for biotechnology testing | Health Services |
Edgepoint, Inc. | |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Health Technology |
Mosaic ImmunoEngineering Development Co.
Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Health Technology |
Mosaic ImmunoEngineering, Inc.
 Mosaic ImmunoEngineering, Inc. BiotechnologyHealth Technology Develops immunotherapy pharmaceuticals | Health Technology |
